Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D)

CompletedOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

June 30, 2022

Conditions

Type 1 Diabetes

Interventions

DIAGNOSTIC_TEST

blood test

assessment of humoral, immune cell response and glycemia

Trial Locations (1)

ASST FBF-Sacco P.O. Sacco, Milan

All Listed Sponsors

collaborator

ASST Fatebenefratelli Sacco

OTHER

lead

Paolo Fiorina, MD

OTHER

NCT04905823 - Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D) | Biotech Hunter | Biotech Hunter